Penumbra Inc (NYSE:PEN) — Market Cap & Net Worth
Market Cap & Net Worth: Penumbra Inc (PEN)
Penumbra Inc (NYSE:PEN) has a market capitalization of $12.44 Billion ($12.44 Billion) as of June 18, 2026. Listed on the NYSE stock exchange, this USA-based company holds position #1915 globally and #708 in its home market, demonstrating a -1.53% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Penumbra Inc's stock price $316.16 by its total outstanding shares 39331425 (39.33 Million). Review total liabilities of Penumbra Inc to assess the company's total debt and financial obligations.
Penumbra Inc Market Cap History: 2015 to 2026
Penumbra Inc's market capitalization history from 2015 to 2026. Data shows growth from $2.12 Billion to $12.44 Billion (21.10% CAGR).
Index Memberships
Penumbra Inc is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
S&P Midcap 400
MID
|
$3.53 Trillion | 0.41% | #72 of 401 |
Weight: Penumbra Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Penumbra Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Penumbra Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
8.71x
Penumbra Inc's market cap is 8.71 times its annual revenue
Latest Price to Earnings (P/E) Ratio
68.82x
Penumbra Inc's market cap is 68.82 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $2.51 Billion | $263.32 Million | $14.81 Million | 9.53x | 169.39x |
| 2017 | $3.70 Billion | $333.76 Million | $4.66 Million | 11.09x | 794.74x |
| 2018 | $4.81 Billion | $444.94 Million | $6.60 Million | 10.80x | 728.12x |
| 2019 | $6.46 Billion | $547.40 Million | $48.46 Million | 11.80x | 133.33x |
| 2020 | $6.88 Billion | $560.41 Million | -$19.26 Million | 12.28x | N/A |
| 2021 | $11.30 Billion | $747.59 Million | $2.62 Million | 15.12x | 4308.31x |
| 2022 | $8.75 Billion | $847.13 Million | -$2.00 Million | 10.33x | N/A |
| 2023 | $9.89 Billion | $1.06 Billion | $90.95 Million | 9.35x | 108.77x |
| 2024 | $9.34 Billion | $1.19 Billion | $14.01 Million | 7.82x | 666.60x |
| 2025 | $12.23 Billion | $1.40 Billion | $177.69 Million | 8.71x | 68.82x |
Competitor Companies of PEN by Market Capitalization
Companies near Penumbra Inc in the global market cap rankings as of June 18, 2026.
Key companies related to Penumbra Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #149 globally with a market cap of $153.89 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #212 globally with a market cap of $115.24 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #236 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #252 globally with a market cap of $100.32 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #149 | Abbott Laboratories | NYSE:ABT | $153.89 Billion | $88.50 |
| #212 | Stryker Corporation | NYSE:SYK | $115.24 Billion | $301.14 |
| #236 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #252 | Medtronic PLC | NYSE:MDT | $100.32 Billion | $78.14 |
Penumbra Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Penumbra Inc's market cap moved from $2.12 Billion to $ 12.44 Billion, with a yearly change of 21.10%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $12.44 Billion | +1.69% |
| 2025 | $12.23 Billion | +30.92% |
| 2024 | $9.34 Billion | -5.59% |
| 2023 | $9.89 Billion | +13.07% |
| 2022 | $8.75 Billion | -22.57% |
| 2021 | $11.30 Billion | +64.18% |
| 2020 | $6.88 Billion | +6.53% |
| 2019 | $6.46 Billion | +34.43% |
| 2018 | $4.81 Billion | +29.86% |
| 2017 | $3.70 Billion | +47.49% |
| 2016 | $2.51 Billion | +18.57% |
| 2015 | $2.12 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 18th, 2026 the market cap of Penumbra Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $12.44 Billion USD |
| MoneyControl | $12.44 Billion USD |
| MarketWatch | $12.44 Billion USD |
| marketcap.company | $12.44 Billion USD |
| Reuters | $12.44 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Penumbra Inc
Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombecto… Read more